These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3042196)
1. Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias. Alaupovic P; McConathy WJ; Fesmire J; Tavella M; Bard JM Clin Chem; 1988; 34(8B):B13-27. PubMed ID: 3042196 [No Abstract] [Full Text] [Related]
2. [Lipid and apolipoprotein levels in health and disease]. Steinerová A; Stozický F; Dudek J; Novák J; Polívková V; Topolcan O; Karlícek V Vnitr Lek; 1987 Feb; 33(2):105-12. PubMed ID: 3824933 [No Abstract] [Full Text] [Related]
3. Effect of elective hospitalization on plasma lipoprotein cholesterol and apolipoproteins A-I, B and Lp(a). Genest JJ; McNamara JR; Ordovas JM; Martin-Munley S; Jenner JL; Millar J; Salem DN; Schaefer EJ Am J Cardiol; 1990 Mar; 65(9):677-9. PubMed ID: 2106773 [No Abstract] [Full Text] [Related]
4. Lipid and apolipoprotein levels in patients with ischaemic heart disease. A comparative study in Plzen and Moscow. Steinerová A; Perova NV; Metel'skaya VA; Topolcan O; Karlícek V; Polívková V Cor Vasa; 1989; 31(4):257-63. PubMed ID: 2509134 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein heterogeneity and its effect on apolipoprotein assays. Fruchart JC Scand J Clin Lab Invest Suppl; 1990; 198():51-7. PubMed ID: 2111936 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays. Bachorik PS; Kwiterovich PO Clin Chim Acta; 1988 Nov; 178(1):1-34. PubMed ID: 3067911 [TBL] [Abstract][Full Text] [Related]
7. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Barbir M; Wile D; Trayner I; Aber VR; Thompson GR Br Heart J; 1988 Nov; 60(5):397-403. PubMed ID: 3203033 [TBL] [Abstract][Full Text] [Related]
9. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group. Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) concentrations as risk indicators for atherosclerosis. Kostner GM; Czinner A; Pfeiffer KH; Bihari-Varga M Arch Dis Child; 1991 Sep; 66(9):1054-6. PubMed ID: 1929512 [TBL] [Abstract][Full Text] [Related]
11. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease]. Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245 [TBL] [Abstract][Full Text] [Related]
12. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra]. Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489 [TBL] [Abstract][Full Text] [Related]
14. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707 [TBL] [Abstract][Full Text] [Related]
15. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the metabolic syndrome by apolipoproteins in the Oklahoma Cherokee. Alaupovic P; Blackett P; Wang W; Lee E J Cardiometab Syndr; 2008; 3(4):193-9. PubMed ID: 19040586 [TBL] [Abstract][Full Text] [Related]
17. Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population. Gajra B; Candlish JK; Saha N; Heng CK; Soemantri AG; Tay JS Genet Epidemiol; 1994; 11(1):19-27. PubMed ID: 8013886 [TBL] [Abstract][Full Text] [Related]
18. Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease. Durrington PN; Ishola M; Hunt L; Arrol S; Bhatnagar D Lancet; 1988 May; 1(8594):1070-3. PubMed ID: 2896911 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease. Kukita H; Hamada M; Hiwada K; Kokubu T Atherosclerosis; 1985 May; 55(2):143-9. PubMed ID: 3924067 [TBL] [Abstract][Full Text] [Related]
20. [Effect of apolipoprotein E gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease]. Zhu T; Wang Z; Zhao S Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):149-51. PubMed ID: 10681829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]